Cargando…

Application of Adenosine Deaminase and γ-Interferon Release Assay in Pleural Fluid for the Diagnosis of Tuberculous Pleural Effusion in Patients Over 40 Years Old

BACKGROUND: In patients with tuberculous pleural effusion (TPE) of various ages, the diagnostic accuracy of pleural biomarkers varies, and there are insufficient studies specifically in different age groups. Therefore, we investigated the adenosine deaminase cut-off value and its combination with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhishu, Chen, Jiayue, Zeng, Jia, Shi, Ping, Xiong, Xiaomin, Wang, Meng, Zheng, Dong, Zhao, Rui, Dong, Lixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942497/
https://www.ncbi.nlm.nih.gov/pubmed/36824067
http://dx.doi.org/10.2147/IDR.S400838
_version_ 1784891513805733888
author Li, Zhishu
Chen, Jiayue
Zeng, Jia
Shi, Ping
Xiong, Xiaomin
Wang, Meng
Zheng, Dong
Zhao, Rui
Dong, Lixia
author_facet Li, Zhishu
Chen, Jiayue
Zeng, Jia
Shi, Ping
Xiong, Xiaomin
Wang, Meng
Zheng, Dong
Zhao, Rui
Dong, Lixia
author_sort Li, Zhishu
collection PubMed
description BACKGROUND: In patients with tuberculous pleural effusion (TPE) of various ages, the diagnostic accuracy of pleural biomarkers varies, and there are insufficient studies specifically in different age groups. Therefore, we investigated the adenosine deaminase cut-off value and its combination with the gamma interferon release assay for the diagnosis of TPE among patients aged ≥40 years. METHODS: A retrospective analysis of 198 patients who underwent medical thoracoscopy and were admitted to the hospital between 2015 and 2020 with exudative pleural effusion and either fever, night sweats, fatigue, cough, or other clinical manifestations was performed. The medical thoracoscopy, ADA, and T-SPOT results were analysed in the pleural fluid. The patients were divided into groups based on age: 18–39, 40–59, and 60–87. RESULTS: The best cut-off values of ADA were 29.5, 31.5 and 19.5 U/L, respectively, for the aged 18–39, aged 40–87 and aged 60–87 groups. The accuracy of 31.5 U/L was higher than 40 U/L for aged ≥40 years (86 vs 83%). The ADA diagnostic accuracy was higher than that of people under 40 years (83 vs 77%) when cut-off value of ADA was 40 U/L, but the IGRA accuracy was lower than that of people under 40 (87 vs 91%). The sensitivity of ADA or IGRA detection in patients over 40 years was 99%, and the specificity was 78%. The ADA specificity combined with IGRA for TPE was the highest (100%) in the ≥40 age group, and the sensitivity was 69%. CONCLUSION: Our study revealed the best cut-off values of ADA for TBE in different age groups. Combining ADA and IGRA in pleural fluid improves the detection rate of TPE in patients over 40 years of age with exudative pleural effusion. ADA combined with IGRA increases specificity, and ADA or IGRA increases sensitivity substantially.
format Online
Article
Text
id pubmed-9942497
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-99424972023-02-22 Application of Adenosine Deaminase and γ-Interferon Release Assay in Pleural Fluid for the Diagnosis of Tuberculous Pleural Effusion in Patients Over 40 Years Old Li, Zhishu Chen, Jiayue Zeng, Jia Shi, Ping Xiong, Xiaomin Wang, Meng Zheng, Dong Zhao, Rui Dong, Lixia Infect Drug Resist Original Research BACKGROUND: In patients with tuberculous pleural effusion (TPE) of various ages, the diagnostic accuracy of pleural biomarkers varies, and there are insufficient studies specifically in different age groups. Therefore, we investigated the adenosine deaminase cut-off value and its combination with the gamma interferon release assay for the diagnosis of TPE among patients aged ≥40 years. METHODS: A retrospective analysis of 198 patients who underwent medical thoracoscopy and were admitted to the hospital between 2015 and 2020 with exudative pleural effusion and either fever, night sweats, fatigue, cough, or other clinical manifestations was performed. The medical thoracoscopy, ADA, and T-SPOT results were analysed in the pleural fluid. The patients were divided into groups based on age: 18–39, 40–59, and 60–87. RESULTS: The best cut-off values of ADA were 29.5, 31.5 and 19.5 U/L, respectively, for the aged 18–39, aged 40–87 and aged 60–87 groups. The accuracy of 31.5 U/L was higher than 40 U/L for aged ≥40 years (86 vs 83%). The ADA diagnostic accuracy was higher than that of people under 40 years (83 vs 77%) when cut-off value of ADA was 40 U/L, but the IGRA accuracy was lower than that of people under 40 (87 vs 91%). The sensitivity of ADA or IGRA detection in patients over 40 years was 99%, and the specificity was 78%. The ADA specificity combined with IGRA for TPE was the highest (100%) in the ≥40 age group, and the sensitivity was 69%. CONCLUSION: Our study revealed the best cut-off values of ADA for TBE in different age groups. Combining ADA and IGRA in pleural fluid improves the detection rate of TPE in patients over 40 years of age with exudative pleural effusion. ADA combined with IGRA increases specificity, and ADA or IGRA increases sensitivity substantially. Dove 2023-02-17 /pmc/articles/PMC9942497/ /pubmed/36824067 http://dx.doi.org/10.2147/IDR.S400838 Text en © 2023 Li et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Li, Zhishu
Chen, Jiayue
Zeng, Jia
Shi, Ping
Xiong, Xiaomin
Wang, Meng
Zheng, Dong
Zhao, Rui
Dong, Lixia
Application of Adenosine Deaminase and γ-Interferon Release Assay in Pleural Fluid for the Diagnosis of Tuberculous Pleural Effusion in Patients Over 40 Years Old
title Application of Adenosine Deaminase and γ-Interferon Release Assay in Pleural Fluid for the Diagnosis of Tuberculous Pleural Effusion in Patients Over 40 Years Old
title_full Application of Adenosine Deaminase and γ-Interferon Release Assay in Pleural Fluid for the Diagnosis of Tuberculous Pleural Effusion in Patients Over 40 Years Old
title_fullStr Application of Adenosine Deaminase and γ-Interferon Release Assay in Pleural Fluid for the Diagnosis of Tuberculous Pleural Effusion in Patients Over 40 Years Old
title_full_unstemmed Application of Adenosine Deaminase and γ-Interferon Release Assay in Pleural Fluid for the Diagnosis of Tuberculous Pleural Effusion in Patients Over 40 Years Old
title_short Application of Adenosine Deaminase and γ-Interferon Release Assay in Pleural Fluid for the Diagnosis of Tuberculous Pleural Effusion in Patients Over 40 Years Old
title_sort application of adenosine deaminase and γ-interferon release assay in pleural fluid for the diagnosis of tuberculous pleural effusion in patients over 40 years old
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942497/
https://www.ncbi.nlm.nih.gov/pubmed/36824067
http://dx.doi.org/10.2147/IDR.S400838
work_keys_str_mv AT lizhishu applicationofadenosinedeaminaseandginterferonreleaseassayinpleuralfluidforthediagnosisoftuberculouspleuraleffusioninpatientsover40yearsold
AT chenjiayue applicationofadenosinedeaminaseandginterferonreleaseassayinpleuralfluidforthediagnosisoftuberculouspleuraleffusioninpatientsover40yearsold
AT zengjia applicationofadenosinedeaminaseandginterferonreleaseassayinpleuralfluidforthediagnosisoftuberculouspleuraleffusioninpatientsover40yearsold
AT shiping applicationofadenosinedeaminaseandginterferonreleaseassayinpleuralfluidforthediagnosisoftuberculouspleuraleffusioninpatientsover40yearsold
AT xiongxiaomin applicationofadenosinedeaminaseandginterferonreleaseassayinpleuralfluidforthediagnosisoftuberculouspleuraleffusioninpatientsover40yearsold
AT wangmeng applicationofadenosinedeaminaseandginterferonreleaseassayinpleuralfluidforthediagnosisoftuberculouspleuraleffusioninpatientsover40yearsold
AT zhengdong applicationofadenosinedeaminaseandginterferonreleaseassayinpleuralfluidforthediagnosisoftuberculouspleuraleffusioninpatientsover40yearsold
AT zhaorui applicationofadenosinedeaminaseandginterferonreleaseassayinpleuralfluidforthediagnosisoftuberculouspleuraleffusioninpatientsover40yearsold
AT donglixia applicationofadenosinedeaminaseandginterferonreleaseassayinpleuralfluidforthediagnosisoftuberculouspleuraleffusioninpatientsover40yearsold